Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Sri Lanka
  4. Colombo Stock Exchange
  5. Sunshine Holdings PLC
  6. News
  7. Summary
    SUN.N0000   LK0160N00008

SUNSHINE HOLDINGS PLC

(SUN.N0000)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Sunshine : appoints Shantha Bandara as CEO of its Pharma Division

07/10/2020 | 04:30am EDT

Sunshine Healthcare Lanka (SHL), the healthcare arm of the diversified Sri Lankan conglomerate Sunshine Holdings, has appointed Shantha Bandara as the Chief Executive Officer of its pharmaceutical division. The appointment came into effect from 1 July.

 table " border="0" cellpadding="1"        Shantha Bandara     Shantha, who was the Chief Operating Officer of Sunshine Pharmaceuticals, counts more than 23 years of experience in the pharmaceutical industry. He joined Sunshine Healthcare in 2011 and rose through the ranks to become the COO in 2018, where he has been spearheading the pharmaceutical business to reach newer heights and become one of the leading healthcare companies in Sri Lanka since then.

He has been instrumental in growing the healthcare business to be the key driver of the Group's financial performance, helping Sunshine Holdings to sustain its growth over the last two years amidst tough macroeconomic conditions.Sunshine Holdings Group Managing Director Vish Govindasamy said: "I would like to congratulate Shantha Bandara on being appointed as the CEO of Sunshine Pharmaceuticals.

During his career at Sunshine Healthcare, Shantha has demonstrated the right combination of talent and drive to step into this key leadership role at the company. He has truly demonstrated a passion for the brand, commitment to his colleagues, and drive to deliver excellence for our principals.

Alongside the outstanding team at Sunshine Pharmaceuticals, I anticipate that the business will experience continued growth under Shantha's leadership."Before joining Sunshine Healthcare, Shantha has held several leadership positions in sales, distribution, supply chain, finance and commercial operations where he has been able to develop strategy, business restructuring, automation and building high-performing teams.

He holds an MBA from the Postgraduate Institute of Management (PIM) University of Sri Jayawardenapura and is an Executive Committee Member of Sunshine Holdings.Sunshine Healthcare has been involved in the healthcare business since 1967 for over half a century after commencing operations as a retail pharmacy in Gampola.

Today, Sunshine Healthcare markets over 650 pharmaceuticals, wellness brands, medical diagnostic equipment and surgical products to all pharmacies and hospitals island-wide and accounts for a significant share of the country's private healthcare sector.

© Pakistan Press International, source Asianet-Pakistan

All news about SUNSHINE HOLDINGS PLC
08/05Sunshine Holdings plc Reports Earnings Results for the First Quarter Ended June 30, 202..
CI
06/02Sunshine Holdings PLC Proposes a Final Cash Dividend
CI
05/25Sunshine Holdings PLC Announces Board Changes
CI
02/04Sunshine Holdings plc Reports Earnings Results for the Third Quarter Ended December 31,..
CI
01/25AKBAR BROTHERS LIMITED COMPLETED THE : Sun.n0000
CI
01/18Sunshine Holdings plc Announces Loan Facility of USD 7,000,000
CI
2020AKBAR BROTHERS LIMITED AGREED TO ACQ : SUN.N0000) for approximately LKR 280 million.
CI
2020Sunshine Holdings plc Reports Earnings Results for the Second Quarter Ended September 3..
CI
2020Sunshine Holdings PLC Appoints Aruni Goonetilleke as Non-Executive, Independent Directo..
CI
2020Sunshine Holdings plc Reports Earnings Results for the First Quarter Ended June 30, 202..
CI
More news
Financials
Sales 2022 29 070 M 146 M 146 M
Net income 2022 4 124 M 20,7 M 20,7 M
Net Debt 2022 - - -
P/E ratio 2022 -
Yield 2022 3,40%
Capitalization 11 217 M 56,1 M 56,2 M
Capi. / Sales 2022 0,39x
Capi. / Sales 2023 0,35x
Nbr of Employees 3 130
Free-Float 9,94%
Chart SUNSHINE HOLDINGS PLC
Duration : Period :
Sunshine Holdings PLC Technical Analysis Chart | SUN.N0000 | LK0160N00008 | MarketScreener
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 2
Last Close Price 25,00 LKR
Average target price 32,45 LKR
Spread / Average Target 29,8%
EPS Revisions
Managers and Directors
Visvanathamoorthy Govindasamy Group Managing Director & Executive Director
Aruna Deepthikumara Group Chief Financial Officer
Munir Ahmad Shaikh Non-Executive Chairman
Harsha Duminda Abeywickrama Independent Non-Executive Director
Asite Drupath Bandara Talwatte Independent Non-Executive Director
Sector and Competitors